Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas
Authors
Keywords
-
Journal
Diagnostics
Volume 11, Issue 1, Pages 107
Publisher
MDPI AG
Online
2021-01-12
DOI
10.3390/diagnostics11010107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages
- (2020) Ismael Sánchez-González et al. CANCER RESEARCH
- miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology
- (2020) Le Chang et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-139 Suppresses the Tumorigenicity of Triple Negative Breast Cancer Cells by Targeting SOX8
- (2020) Liangliang Dong et al. Cancer Management and Research
- The Regulatory Role of Mitochondrial MicroRNAs (MitomiRs) in Breast Cancer: Translational Implications Present and Future
- (2020) Miguel A. Ortega et al. Cancers
- Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
- (2019) Chara Papadaki et al. Oncotarget
- microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
- (2019) Hui Wang et al. BMC CANCER
- MiR-539 inhibited the malignant behaviors of breast cancer cells by targeting SP1
- (2019) Fenglin Cai et al. Biochemistry and Cell Biology
- A Novel Bioengineered MicroRNA-127 Prodrug Suppresses The Growth And Metastatic Potential Of Triple Negative Breast Cancer Cells
- (2019) Maxine Umeh-Garcia et al. CANCER RESEARCH
- Tumor-suppressor role of miR-139-5p in endometrial cancer
- (2018) JinHui Liu et al. Cancer Cell International
- The Nefarious Nexus of Noncoding RNAs in Cancer
- (2018) Eleni Anastasiadou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Breast cancer diagnosis: Imaging techniques and biochemical markers
- (2018) Seyed Hamed Jafari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process
- (2018) Alireza Khodadadi-Jamayran et al. Oncotarget
- Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer
- (2018) Peng Zhang et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5
- (2018) Bin Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-30a inhibits the biological function of breast cancer cells by targeting Notch1
- (2017) He-Da Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
- (2017) Wenrui Wang et al. Cell Death & Disease
- LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
- (2017) Xiuhui Shi et al. Oncotarget
- Use of cell free DNA in breast oncology
- (2016) Jenna VanLiere Canzoniero et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Imaging techniques: new avenues in cancer gene and cell therapy
- (2016) Z Saadatpour et al. CANCER GENE THERAPY
- Molecular imaging and cancer gene therapy
- (2016) Z Saadatpour et al. CANCER GENE THERAPY
- Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors
- (2016) Yu-Mee Sohn et al. Iranian Journal of Radiology
- Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
- (2016) Ricardo Costa et al. Oncotarget
- Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
- (2016) Krithika N. Kodumudi et al. PLoS One
- Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease
- (2015) Joseph Inns et al. BREAST
- Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
- (2015) V Y Shin et al. BRITISH JOURNAL OF CANCER
- Anti-PD-L1 for metastatic triple-negative breast cancer
- (2015) Josefine Gibson LANCET ONCOLOGY
- The biology of circulating tumor cells
- (2015) K Pantel et al. ONCOGENE
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
- (2015) Jie Shen et al. Oncotarget
- Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
- (2014) Sonia A. Melo et al. CANCER CELL
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence
- (2014) Amy Braden et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer
- (2013) C. Zielinski et al. ANNALS OF ONCOLOGY
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
- (2013) Enders K. O. Ng et al. PLoS One
- MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells
- (2013) Enders K. O. Ng et al. TUMOR BIOLOGY
- Sensitive PCR-based quantitation of cell-free circulating microRNAs
- (2012) Michelle L. Hastings et al. METHODS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours
- (2012) Victoria J. Cookson et al. CELLULAR ONCOLOGY
- Accuracy of Screening Mammography in Older Women
- (2011) Natalie Sinclair et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Will Molecular Classification Replace Traditional Breast Pathology?
- (2010) Stuart J. Schnitt INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Accuracy of Screening Mammography Varies by Week of Menstrual Cycle
- (2010) Diana L. Miglioretti et al. RADIOLOGY
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation